IS

Inderjot Singh

Director Director DIN 03090908
DIN 03090908 First appointment Sep 2010 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Inderjot Singh

Data last updated:

Inderjot Singh was a Director at Stevels Pharma Limited (2013–2017) and Director at Adway Biotech Private Limited (from 2010). The companies operate in Pharma.

DIN 03090908
Primary Designation Director
Industry Pharma
First Appointment 21 Sep 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stevels Pharma Limited U24230CH2004PLC027156
Director07 Mar 20132004₹52.4 Lakh (FY 2021)Active
Adway Biotech Private Limited U24232PB2010PTC034287
Director21 Sep 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Adway Biotech Private Limited
Stevels Pharma Limited
Premium access

Shareholding and investment profile for Inderjot Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Inderjot Singh

Inderjot Singh was first appointed on 21 Sep 2010 as Director at Adway Biotech Private Limited. The most recent appointment on record is 07 Mar 2013 at Stevels Pharma Limited.

Inderjot Singh held 2 earlier board appointments: Stevels Pharma Limited (Director, 07 Mar 2013 to 31 Oct 2017); Adway Biotech Private Limited (Director, from 21 Sep 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available